Compare · COCH vs STE
COCH vs STE
Side-by-side comparison of Envoy Medical Inc. (COCH) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COCH and STE operate in Industrial Specialties (Health Care), so they compete in similar markets.
- STE is the larger of the two at $21.23B, about 417.1x COCH ($50.9M).
- Over the past year, COCH is down 29.8% and STE is down 5.2% - STE leads by 24.6 points.
- Both names hit the wire about 4 times in the past 4 weeks.
- STE has more recent analyst coverage (17 ratings vs 3 for COCH).
- Company
- Envoy Medical Inc.
- STERIS plc (Ireland)
- Price
- $0.63-3.73%
- $224.39+3.27%
- Market cap
- $50.9M
- $21.23B
- 1M return
- -13.62%
- +6.92%
- 1Y return
- -29.80%
- -5.25%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 4
- 4
- Recent ratings
- 3
- 17
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest COCH
- Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant
- SEC Form 8-K filed by Envoy Medical Inc.
- Lake Street initiated coverage on Envoy Medical with a new price target
- Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
- SEC Form DEFA14A filed by Envoy Medical Inc.
- Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th
- SEC Form DEF 14A filed by Envoy Medical Inc.
- Envoy Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 4 filed by CAO & VP of Finance Potashnick Robert
- SEC Form PRE 14A filed by Envoy Medical Inc.
Latest STE
- SEC Form 8-K filed by STERIS plc (Ireland)
- Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)
- STERIS Expands Healthcare Consumables Offering with Definitive Agreement to Acquire Xodus Medical, a Specialty Surgical Products Business Focused on Patient and OR Staff Safety
- SEC Form 4 filed by STERIS plc (Ireland)
- STERIS to Present at the Morgan Stanley Healthcare Conference
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 4 filed by Director Shapiro Louis
- Director Sohi Mohsen exercised 4,058 units of Ordinary Shares at a strike of $86.23 and sold $956,795 worth of Ordinary Shares (4,058 units at $235.78) (SEC Form 4)
- SEC Form 4 filed by Director Shah Nirav R
- SEC Form 4 filed by Director Martin Paul Edward